Vcanbio Cell & Gene Engineering Corp., Ltd reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 774.94 million compared to CNY 745.34 million a year ago. Revenue was CNY 798.07 million compared to CNY 768.8 million a year ago.

Net income was CNY 82.67 million compared to CNY 64.83 million a year ago. Basic earnings per share from continuing operations was CNY 0.18 compared to CNY 0.14 a year ago. Diluted earnings per share from continuing operations was CNY 0.18 compared to CNY 0.14 a year ago.